Javid J. Moslehi
University of California, San Francisco(US)Cardiovascular Institute of the South(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Chemotherapy-induced cardiotoxicity and mitigation, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral Infections and Immunology Research
Most-Cited Works
- → Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors(2018)2,518 cited
- → 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)(2022)2,509 cited
- → Fulminant Myocarditis with Combination Immune Checkpoint Blockade(2016)2,219 cited
- → Myocarditis in Patients Treated With Immune Checkpoint Inhibitors(2018)1,482 cited
- → Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging(2013)1,438 cited
- → Telomere dysfunction induces metabolic and mitochondrial compromise(2011)1,282 cited